Yun Kim

Assistant Professor

Daegu University

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yun Kim is an Assistant Professor at Daegu Catholic University in South Korea. His research areas include pharmacokinetics, drug interactions, and the safety and efficacy of novel therapeutic agents, particularly in the context of metabolic and liver diseases. Recent contributions to the field include studies on sodium–glucose cotransporter inhibitors and orphan drug oversight by regulatory agencies.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Sang W. Lee

SOUTH KOREA

View details

Inyoung Hwang

Clinical Assistant Professor

Seoul National University Hospital

SOUTH KOREA

View details

Jun Gi Hwang

Clinical assistant professor

Chungbuk National University Hospital

SOUTH KOREA

View details

YOONJIN ROH

Research Professor

Chung-Ang University

SOUTH KOREA

View details

Jonghyun Lee

University of Pennsylvania

UNITED STATES

View details

Kyung-Sang Yu

SOUTH KOREA

View details

Byungwook Kim

Clinical Professor

Seoul National University Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yun Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Safety, Pharmacokinetics, and Food Effect of the RORα Agonist TB-840, a Novel Candidate for Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Randomized First-in-Human Study in Healthy Volunteers

Identifying signals of disproportionate reporting for calcitonin gene-related peptide inhibitors: real-world evidence from the FDA adverse event reporting system

Assessing Post‐Marketing Requirements for Orphan Drugs: A Cross‐Sectional Analysis of FDA and EMA Oversight

Optimal Once-Daily Busulfan Administration in Pediatric Patients: A Simulation-Based Investigation of Intravenous Infusion Times

Synthesis of protected 1,4-trans-1,5-cis-4,5-diamino-2-cyclopenten-1-ol via stereoselective vinylation of α-amino aldimine

Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium–glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults

Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium–glucose cotransporter 2 inhibitor and metformin in healthy subjects

The Drug-Like Molecule Pre-Training Strategy for Drug Discovery

ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model

Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease

Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects

Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients

Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK-30, and From Red Ginseng Extract in Healthy Korean Subjects.

Population pharmacokinetic/pharmacodynamic modeling of delayed effect of escitalopram-induced QT prolongation

Collaborators (7)

Sang W. Lee

Inyoung Hwang

Jun Gi Hwang

YOONJIN ROH

Jonghyun Lee

Kyung-Sang Yu

Byungwook Kim

Make your next move.